In particular, the CSC markers CD133 and Sox2 were upregulated in U87MG and U251 glioma cells stably overexpressing HSP90 (oe-HSP90) and downregulated after HSP90 knockdown (sh-HSP90) [20]. Here, SOX2 is linked to central nervous system cancer.